SciTransfer
Organization

LIFEGLIMMER GMBH

Berlin bioinformatics SME providing systems biology data analysis and multi-omics integration for health research and industrial biotech consortia.

Technology SMEhealthDESME
H2020 projects
7
As coordinator
0
Total EC funding
€1.3M
Unique partners
86
What they do

Their core work

LifeGlimmer is a Berlin-based bioinformatics and systems biology SME that provides computational data analysis services to life science research consortia. They specialize in multi-omics data integration, systems analytics, and knowledge retrieval — essentially translating complex biological datasets into actionable insights. Their work spans from cancer metabolism and cell biology to occupational health and personalized medicine, always in the role of the computational partner that makes sense of large-scale biological data.

Core expertise

What they specialise in

Systems biology and multi-omics data analysisprimary
5 projects

Core computational partner across Chromatin3D, HaemMetabolome, PERICO, TranSYS, and EPHOR — all requiring integration of complex biological datasets.

Personalized medicine and biomarker discoveryprimary
2 projects

TranSYS focused on translational systemics for personalized medicine; EPHOR applies omics-based approaches to occupational health biomarkers.

Occupational and environmental health analyticsemerging
1 project

EPHOR (2020-2025) applies exposome research, cohort studies, and sensor data integration to occupational health — a newer direction.

Cell biology and organelle researchsecondary
2 projects

PERICO (peroxisome interactions) and Chromatin3D (chromatin dynamics) involve computational modeling of subcellular processes.

Evolution & trajectory

How they've shifted over time

Early focus
Molecular biology data analytics
Recent focus
Translational health and exposomics

In their early H2020 period (2015-2018), LifeGlimmer focused on fundamental molecular biology — chromatin dynamics, cancer metabolism, and industrial biotechnology with Pseudomonas putida. From 2018 onward, their work shifted decisively toward translational applications: peroxisome systems biology, personalized medicine with sample-to-insight analytics, and occupational health exposomics. This trajectory shows a company moving from basic biological data analysis toward applied, patient- and worker-oriented health research with stronger emphasis on AI and multi-faceted knowledge retrieval.

LifeGlimmer is moving from fundamental research support toward applied health data analytics, with growing interest in AI-driven knowledge retrieval and real-world health outcome prediction.

Collaboration profile

How they like to work

Role: specialist_contributorReach: European21 countries collaborated

LifeGlimmer has never coordinated an H2020 project — they consistently join as a specialist participant or third-party contributor, which is typical for computational SMEs that provide analytical services rather than driving research agendas. With 86 unique partners across 21 countries, they operate as a highly networked service provider embedded in diverse consortia rather than a hub with a fixed circle. This makes them an easy plug-in partner: experienced in large consortia, low coordination overhead, and comfortable adapting to different research domains.

Remarkably broad network for a small company: 86 unique consortium partners across 21 countries, reflecting their role as a versatile computational partner welcomed into diverse research teams across Europe and beyond.

Why partner with them

What sets them apart

LifeGlimmer occupies a specific niche as a private bioinformatics SME that bridges computational systems biology with applied health research — a combination rare among German SMEs. Unlike university bioinformatics groups, they bring commercial agility and cross-domain flexibility, having worked across cancer, industrial biotech, cell biology, and occupational health. For consortium builders, they offer a reliable computational work package partner with proven track record in MSCA training networks and RIA projects alike.

Notable projects

Highlights from their portfolio

  • EmPowerPutida
    Largest single funding (EUR 581,750) — industrial biotechnology project for re-engineering Pseudomonas putida, showing LifeGlimmer's capacity beyond pure health research.
  • TranSYS
    Personalized medicine training network combining biomarker discovery, clinical trials design, and AI-driven sample-to-insight analytics — represents their most translational work.
  • EPHOR
    Their most recent project (2020-2025), applying exposome research with sensors and omics to occupational health — signals their future direction.
Cross-sector capabilities
Industrial biotechnology and synthetic biologyEnvironmental and occupational health monitoringAI and data analytics for life sciencesResearch training and capacity building (MSCA networks)
Analysis note: Profile is based on 7 projects with moderate keyword data. LifeGlimmer's exact service offerings are inferred from their consistent role as computational/analytical partner across diverse biological domains. Two projects (Chromatin3D, HaemMetabolome) were third-party contributions with no funding data, suggesting smaller or subcontracted roles. Website verification recommended for current service portfolio.